Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Mackinnon

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Blood Advances|October 26, 2021
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantationRachael Hough, Andre Lopes, Pip Patrick, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Haematologica|November 28, 2015
Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donorsEsteban Arrieta-Bolaños, Neema P Mayor, Steven G E Marsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignanciesKatharine Branson, Rajesh Chopra, Panagiotis D Kottaridis, et al.
Haematologica|November 2, 2020
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft functionMaria M Cuadrado, Richard M Szydlo, Mike Watts, et al.
Blood Advances|December 24, 2019
Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter studyEmma Das-Gupta, Kirsty J Thomson, Adrian J C Bloor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasiaSudhir Tauro, Charles Craddock, Karl Peggs, et al.
Blood|May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitutionSuparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
Haematologica|August 4, 2009
Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionBella Patel, Keiren E Kirkland, Richard Szydlo, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Blood Advances|October 26, 2021
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantationRachael Hough, Andre Lopes, Pip Patrick, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Haematologica|November 28, 2015
Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donorsEsteban Arrieta-Bolaños, Neema P Mayor, Steven G E Marsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignanciesKatharine Branson, Rajesh Chopra, Panagiotis D Kottaridis, et al.
Haematologica|November 2, 2020
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft functionMaria M Cuadrado, Richard M Szydlo, Mike Watts, et al.
Blood Advances|December 24, 2019
Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter studyEmma Das-Gupta, Kirsty J Thomson, Adrian J C Bloor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasiaSudhir Tauro, Charles Craddock, Karl Peggs, et al.
Blood|May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitutionSuparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
Haematologica|August 4, 2009
Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionBella Patel, Keiren E Kirkland, Richard Szydlo, et al.
Pageof 11